Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2003 1
2004 1
2005 1
2006 1
2007 2
2008 6
2009 7
2010 5
2011 3
2012 4
2013 4
2014 4
2015 5
2016 3
2017 3
2018 4
2019 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Chronic interstitial lung diseases in children: diagnosis approaches.
Nathan N, Berdah L, Borensztajn K, Clement A. Nathan N, et al. Among authors: borensztajn k. Expert Rev Respir Med. 2018 Dec;12(12):1051-1060. doi: 10.1080/17476348.2018.1538795. Epub 2018 Oct 31. Expert Rev Respir Med. 2018. PMID: 30345849 Review.
Protean proteases: at the cutting edge of lung diseases.
Taggart C, Mall MA, Lalmanach G, Cataldo D, Ludwig A, Janciauskiene S, Heath N, Meiners S, Overall CM, Schultz C, Turk B, Borensztajn KS. Taggart C, et al. Among authors: borensztajn ks. Eur Respir J. 2017 Feb 8;49(2):1501200. doi: 10.1183/13993003.01200-2015. Print 2017 Feb. Eur Respir J. 2017. PMID: 28179435 Free article. Review.
Protease-activated receptors, apoptosis and tumor growth.
Borensztajn KS, Spek CA. Borensztajn KS, et al. Pathophysiol Haemost Thromb. 2008;36(3-4):137-47. doi: 10.1159/000175152. Epub 2009 Jan 27. Pathophysiol Haemost Thromb. 2008. PMID: 19176987 Review.
Systemic inflammatory syndrome in children with FARSA deficiency.
Charbit-Henrion F, Goguyer-Deschaumes R, Borensztajn K, Mirande M, Berthelet J, Rodrigues-Lima F, Khiat A, Frémond ML, Bader-Meunier B, Rodari MM, Seabra L, Rice GI, Legendre M, Drummond D, Berteloot L, Roux CJ, Boddaert N, Drabent P, Molina TJ, Lacaille F, Kossorotoff M, Cerf-Bensussan N, Parlato M, Hadchouel A. Charbit-Henrion F, et al. Among authors: borensztajn k. Clin Genet. 2022 May;101(5-6):552-558. doi: 10.1111/cge.14120. Epub 2022 Feb 17. Clin Genet. 2022. PMID: 35132614 Free PMC article.
Blood coagulation factor Xa as an emerging drug target.
Borensztajn K, Spek CA. Borensztajn K, et al. Expert Opin Ther Targets. 2011 Mar;15(3):341-9. doi: 10.1517/14728222.2011.553608. Epub 2011 Jan 21. Expert Opin Ther Targets. 2011. PMID: 21250873 Review.
Combination therapy: the future of management for idiopathic pulmonary fibrosis?
Wuyts WA, Antoniou KM, Borensztajn K, Costabel U, Cottin V, Crestani B, Grutters JC, Maher TM, Poletti V, Richeldi L, Vancheri C, Wells AU. Wuyts WA, et al. Among authors: borensztajn k. Lancet Respir Med. 2014 Nov;2(11):933-942. doi: 10.1016/S2213-2600(14)70232-2. Epub 2014 Nov 3. Lancet Respir Med. 2014. PMID: 25439569 Review.
53 results